
Johnson & Johnson plans to deliver 20 million doses of its COVID-19 vaccine candidate to the United States by the end of March if the Food and Drug Administration authorizes emergency use of the single-dose vaccine, a company executive told a House subcommittee at a hearing on expanding vaccine availability.